日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival

转移性黑色素瘤患者接受伊匹木单抗治疗期间血浆蛋白动态变化:与肿瘤反应、不良事件和生存率的关系

Lereim, Ragnhild Reehorst; Dunn, Claire; Aamdal, Elin; Chauhan, Sudhir Kumar; Straume, Oddbjørn; Guren, Tormod Kyrre; Kyte, Jon Amund

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

接种长肽癌症疫苗 UV1 后持久且动态的 hTERT 免疫反应:三项 I 期临床试验的长期随访

Espen Basmo Ellingsen, Elin Aamdal, Tormod Guren, Wolfgang Lilleby, Paal F Brunsvig, Sara M Mangsbo, Steinar Aamdal, Eivind Hovig, Nadia Mensali, Gustav Gaudernack, Else Marit Inderberg0

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

接受伊匹木单抗治疗的晚期黑色素瘤患者的健康相关生活质量:预后意义和治疗期间的变化

Aamdal, E; Skovlund, E; Jacobsen, K D; Straume, O; Kersten, C; Herlofsen, O; Karlsen, J; Hussain, I; Amundsen, A; Dalhaug, A; Nyakas, M; Hagene, K T; Holmsen, K; Aamdal, S; Kaasa, S; Guren, T K; Kyte, J A

Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination

伊匹单抗和 hTERT 疫苗联合治疗后 T 细胞受体库和黑色素瘤肿瘤微环境的表征

Espen Basmo Ellingsen, Gergana Bounova, Iliana Kerzeli, Irantzu Anzar, Donjete Simnica, Elin Aamdal, Tormod Guren, Trevor Clancy, Artur Mezheyeuski, Else Marit Inderberg, Sara M Mangsbo, Mascha Binder, Eivind Hovig, Gustav Gaudernack4

Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial

免疫学和分子特征与克唑替尼治疗肺泡软组织肉瘤疗效的相关性:一项与 EORTC 90101“CREATE”试验相关的探索性研究

Lee, Che-Jui; Modave, Elodie; Boeckx, Bram; Kasper, Bernd; Aamdal, Steinar; Leahy, Michael G; Rutkowski, Piotr; Bauer, Sebastian; Debiec-Rychter, Maria; Sciot, Raf; Lambrechts, Diether; Wozniak, Agnieszka; Schöffski, Patrick

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

将通用端粒酶癌症疫苗与伊匹单抗联合用于转移性黑色素瘤患者 - I/IIa 期临床试验的五年随访

Elin Aamdal, Else Marit Inderberg, Espen Basmo Ellingsen, Wenche Rasch, Paal Fredrik Brunsvig, Steinar Aamdal, Karen-Marie Heintz, Daniel Vodák, Sigve Nakken, Eivind Hovig, Marta Nyakas, Tormod Kyrre Guren, Gustav Gaudernack

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer

第二代端粒酶疫苗 UV1 对晚期非小细胞肺癌患者进行的 I 期研究的长期结果

Paal F Brunsvig, Tormod Kyrre Guren, Marta Nyakas, Claudius H Steinfeldt-Reisse, Wenche Rasch, Jon Amund Kyte, Hedvig Vidarsdotter Juul, Steinar Aamdal, Gustav Gaudernack, Else Marit Inderberg

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma

转移性黑色素瘤伊匹单抗免疫治疗的预后生物标志物

M Nyakas, E Aamdal, K D Jacobsen, T K Guren, S Aamdal, K T Hagene, P Brunsvig, A Yndestad, B Halvorsen, K A Tasken, P Aukrust, G M Maelandsmo, T Ueland

Thiophenone Attenuates Enteropathogenic Escherichia coli O103:H2 Virulence by Interfering with AI-2 Signaling

噻吩酮通过干扰 AI-2 信号减弱肠致病性大肠杆菌 O103:H2 的毒力

Ingun Lund Witsø, Håkon Valen Rukke, Tore Benneche, Anne Aamdal Scheie

Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells

晚期黑色素瘤患者接种肿瘤 mRNA 转染树突状细胞后的免疫反应和长期临床结果

Jon Amund Kyte, Steinar Aamdal, Svein Dueland, Stein Sæbøe-Larsen, Else Marit Inderberg, Ulf Erik Madsbu, Eva Skovlund, Gustav Gaudernack, Gunnar Kvalheim